Homebiotech

biotech

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026

biotech

Meteor Biotech joins brain organoids consortium

Jim Cornall - June 25, 2026

biotech

Can food influence gene activity?

Jim Cornall - June 24, 2026

biotech

Lab-engineered proteins: a promising treatment for liver disease

Jim Cornall - June 24, 2026

biotech

MetaVia collaborating with Syntekabio to boost drug options

Jim Cornall - August 11, 2025

AI

Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA

Jim Cornall - August 8, 2025

biotech

Ofichem expands capabilities with Swedish site acquisition

Jim Cornall - August 7, 2025

biotech

Genentech provides positive update on wet AMD drug

Jim Cornall - August 7, 2025

biotech

Concept Life Sciences and Fios Genomics partner to enhance complex data analysis in drug discovery

Jim Cornall - August 7, 2025

biotech

ESTEVE CDMO expands US footprint with Regis Technologies acquisition

Jim Cornall - August 6, 2025

biotech

Hepatocellular carcinoma in the crosshairs with new treatment

Jim Cornall - August 6, 2025

biotech

A new path in cancer immunotherapy

Jim Cornall - August 6, 2025

1...686970...85 Page 69 of 85

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026 0

Memento Medicines, Inc., a privately-held biotech company developing biologic therapies for retinal diseases, has complete a $93m Series A financing round co-led by Forbion,...

Meteor Biotech joins brain organoids consortium

biotech Jim Cornall - June 25, 2026 0

Can food influence gene activity?

biotech Jim Cornall - June 24, 2026 0

Lab-engineered proteins: a promising treatment for liver disease

biotech Jim Cornall - June 24, 2026 0

Insilico Medicine And SK Biopharmaceuticals to collaborate in $2.5bn deal

biotech Jim Cornall - June 24, 2026 0